AURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH)

NCT03028740 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
1778
Enrollment
INDUSTRY
Sponsor class

Stopped This study was terminated early due to lack of efficacy based on the results of the planned interim analysis of Part 1 data.

Conditions

Interventions

Sponsor

Tobira Therapeutics, Inc.